🇺🇸 FDA

Company profile · Sponsor

Zhongnan

Zhongnan Hospital

C173D73 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Zhongnan (C173D73) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C173D73
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. 68Ga-pentixafor

    Zhongnan

    CXCR4

    small molecule active

    1 trial

  2. Hydrochloride anlotinib

    Zhongnan

    Uterine Cervical Neoplasms

    small molecule active

    1 trial

Frequently asked questions

What is Zhongnan?

Zhongnan (C173D73) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Zhongnan sponsor?

We track 2 ClinicalTrials.gov-linked programs for Zhongnan, including 68Ga-pentixafor and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Zhongnan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.